OHSU Advanced Heart Failure & Transplant Program Reaches Landmark

The OHSU Advanced Heart Failure and Transplant Team recently performed the Program’s 600th heart transplant. This signature event marks a distinguished history that began with the program’s first heart transplant in December 1985, more than 27 years ago.  Since then, the OHSU Advanced Heart Failure and Transplant Program has established a tradition of providing outstanding care to patients with advanced cardiovascular disease.  OHSU is the only heart transplant center in Oregon and has the largest experience with ventricular assist devices.

The OHSU Advanced Heart Failure and Transplant Program offers comprehensive care for heart failure patients, including augmented medical therapy, at home continuous inotrope infusions, and ventricular assist devices, in addition to heart transplantation. 

The OHSU Advanced Heart Failure and Transplant Team is part of the Knight Cardiovascular Institute, which was established through a visionary $125 million philanthropic investment from Nike co-founder and chairman Phil Knight and his wife, Penny. It is the largest gift ever recorded to advance cardiovascular health in the United States. The Knight Cardiovascular Institute is an integrated center of translational research, clinical care, education and disease prevention, which is dedicated to becoming the world’s best at translating research into clinical innovations to benefit patients by attacking heart disease from every angle, before conception and throughout a person’s lifetime.